| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble recombinant variant of the neuregulin-1b1 protein, which is being explored for its potential in treating Parkinson's disease and various other …
Over the last 12 months, insiders at Minerva Neurosciences, Inc. have bought $0 and sold $0 worth of Minerva Neurosciences, Inc. stock.
On average, over the past 5 years, insiders at Minerva Neurosciences, Inc. have bought $0 and sold $127,576 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,000 shares for transaction amount of $20,790 was made by VAN HEEK G JAN (director) on 2020‑09‑10.
| 2023-05-02 | Sale | Luthringer Remy | CEO | 3,641 0.0559% | $3.76 | $13,690 | +44.12% | |
| 2023-05-01 | Sale | Luthringer Remy | CEO | 23,753 0.4554% | $3.85 | $91,449 | +75.93% | |
| 2023-05-01 | Sale | Race Geoff | President | 22,082 0.4234% | $3.85 | $85,016 | +75.93% | |
| 2023-05-01 | Sale | Ahlholm Frederick W | SVP, CFO and Secretary | 3,580 0.0799% | $4.48 | $16,038 | +75.93% | |
| 2021-12-01 | Sale | Kupfer David | director | 55,635 0.1267% | $0.88 | $48,959 | -24.72% | |
| 2020-12-16 | Sale | Race Geoff | EVP, CFO & CBO | 6,190 0.0149% | $2.64 | $16,342 | -10.31% | |
| 2020-12-16 | Sale | Luthringer Remy | CEO | 1,300 0.0031% | $2.64 | $3,432 | -10.31% | |
| 2020-12-16 | Sale | Reilly Joseph H. | SVP & Chief Operating Officer | 3,228 0.0078% | $2.64 | $8,522 | -10.31% | |
| 2020-12-16 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 1,845 0.0044% | $2.64 | $4,871 | -10.31% | |
| 2020-09-10 | VAN HEEK G JAN | director | 7,000 0.0171% | $2.97 | $20,790 | -0.86% | ||
| 2020-05-26 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 8,339 0.0216% | $15.00 | $125,085 | -78.03% | |
| 2019-12-17 | Sale | Race Geoff | EVP, CFO & CBO | 5,826 0.0152% | $7.10 | $41,365 | -46.98% | |
| 2019-12-17 | Sale | Luthringer Remy | CEO | 2,412 0.0063% | $7.10 | $17,125 | -46.98% | |
| 2019-12-17 | Sale | Reilly Joseph H. | SVP & Chief Operating Officer | 2,724 0.0071% | $7.10 | $19,340 | -46.98% | |
| 2019-12-17 | Sale | Ahlholm Frederick W | SVP, Chief Accounting Officer | 1,557 0.0041% | $7.10 | $11,055 | -46.98% | |
| 2019-12-12 | Sale | Russell Richard E. | President | 3,113 0.0078% | $7.42 | $23,098 | -50.13% | |
| 2019-06-27 | DOYLE WILLIAM F | director | 3,500 0.009% | $5.50 | $19,250 | +23.53% | ||
| 2019-06-26 | Kupfer David | director | 10,000 0.0264% | $5.55 | $55,500 | +25.05% | ||
| 2019-06-26 | VAN HEEK G JAN | director | 10,000 0.0255% | $5.37 | $53,700 | +25.05% | ||
| 2019-06-26 | HASLER HANS PETER | director | 10,000 0.0266% | $5.60 | $56,000 | +25.05% |
| Ollier Michele | 4488272 9.4% | $10.55M | 2 | 1 | <0.0001% | |
| De Rubertis Francesco | 4488272 9.4% | $10.55M | 2 | 1 | <0.0001% | |
| Index Venture Associates III Ltd | 10 percent owner | 3899189 8.1663% | $9.16M | 2 | 18 | <0.0001% |
| JOHNSON & JOHNSON | 10 percent owner | 3892256 8.1517% | $9.15M | 2 | 0 | <0.0001% |
| Pellegrini Lorenzo | 3883212 8.1328% | $9.13M | 1 | 0 | <0.0001% | |
| Care Capital III LLC | 10 percent owner | 1662592 3.482% | $3.91M | 1 | 7 | <0.0001% |
| Kupfer David | director | 163553 0.3425% | $384,349.55 | 4 | 1 | <0.0001% |
| Race Geoff | President | 51324 0.1075% | $120,611.40 | 1 | 7 | <0.0001% |
| Beer Marc D | director | 50000 0.1047% | $117,500.00 | 2 | 0 | <0.0001% |
| Vivaldi Coelho Rogerio | President and CEO | 41667 0.0873% | $97,917.45 | 1 | 0 | <0.0001% |
| Reilly Joseph H. | SVP & Chief Operating Officer | 31747 0.0665% | $74,605.45 | 1 | 7 | <0.0001% |
| DOYLE WILLIAM F | director | 26111 0.0547% | $61,360.85 | 11 | 0 | <0.0001% |
| VAN HEEK G JAN | director | 20333 0.0426% | $47,782.55 | 3 | 0 | <0.0001% |
| Ahlholm Frederick W | SVP, CFO and Secretary | 17518 0.0367% | $41,167.30 | 1 | 8 | <0.0001% |
| HASLER HANS PETER | director | 10000 0.0209% | $23,500.00 | 1 | 0 | |
| HILLEMAN JERYL L | director | 1000 0.0021% | $2,350.00 | 1 | 0 |
$5,552,811 | 165 | 5.84% | $106.2M | |
$16,280,851 | 76 | 1.48% | $118.27M | |
$4,898,715 | 46 | 40.75% | $114.69M | |
$130,095 | 43 | 45.19% | $111.24M | |
$47,438,336 | 33 | -21.38% | $122.37M |
| Increased Positions | 22 | +88% | 21M | +1,067.25% |
| Decreased Positions | 9 | -36% | 36,318 | -1.83% |
| New Positions | 14 | New | 17M | New |
| Sold Out Positions | 5 | Sold Out | 22,745 | Sold Out |
| Total Postitions | 38 | +52% | 23M | +1,065.42% |
| Federated Hermes, Inc. | $5,297.00 | 3.14% | 1.35M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $988.00 | 0.59% | 252,029 | -31 | -0.01% | 2025-09-30 |
| Renaissance Technologies Llc | $457.00 | 0.27% | 116,500 | +5,500 | +4.96% | 2025-09-30 |
| Geode Capital Management, Llc | $296.00 | 0.18% | 75,625 | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $285.00 | 0.17% | 72,669 | 0 | 0% | 2025-09-30 |
| Apella Capital, Llc | $154.00 | 0.09% | 39,314 | +18,375 | +87.75% | 2025-09-30 |
| Acadian Asset Management Llc | $68.00 | 0.04% | 17,416 | 0 | 0% | 2025-09-30 |
| State Street Corp | $65.00 | 0.04% | 16,519 | 0 | 0% | 2025-09-30 |
| Adar1 Capital Management, Llc | $49.00 | 0.03% | 12,406 | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $43.00 | 0.03% | 11,008 | 0 | 0% | 2025-09-30 |